Table 3. UNHS meta-analysis study quality scoring results.
Study | PCHL definition | Other concerns | Clear protocol | Clear at-risk protocol | Sample bias | UNHS coverage | UNHS follow-up | Overall follow-up |
---|---|---|---|---|---|---|---|---|
De Capua | 2 | 1 | 1 | 1 | 1 | 0 | 1 | 1 |
O'Connor | 2 | 1 | 1 | 1 | 1 | 1 | n/a | 1 |
Calcutt | 2 | 1 | 1 | 1 | 0 | 1 | n/a | 1 |
Calevo | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Magnani | 2 | 1 | 0 | 1 | 1 | 1 | 1 | 0 |
Mason | 2 | 1 | 1 | 1 | 0 | 1 | 1 | 0 |
Ng | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 |
Caluraud | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 0 |
Guastini | 1 | 1 | 1 | 1 | 1 | n/a | 1 | 0 |
Uilenburg | 2 | 1 | 1 | 1 | 0 | 0 | 1 | 0 |
Uus | 2 | 1 | 1 | 1 | 1 | n/a | n/a | 0 |
White | 2 | 1 | 1 | 1 | 0 | n/a | 1 | 0 |
Almenar Latorre | 1 | 0 | 1 | 1 | 0 | n/a | 1 | 1 |
Gonzalez de Aledo Linos | 1 | 1 | 1 | 0 | 1 | 1 | n/a | 0 |
Habib | 2 | 1 | 1 | 0 | 0 | 0 | 1 | 0 |
NSW | 1 | 1 | 0 | 0 | 1 | 1 | 1 | 0 |
Van der Ploeg | 1 | 1 | 1 | 1 | 0 | 1 | n/a | 0 |
Watkin | 1 | 1 | 0 | 0 | 1 | 1 | n/a | 1 |
Wessex | 1 | 1 | 1 | 1 | 0 | 0 | n/a | 1 |
Adelola | 1 | 0 | 0 | 1 | 1 | 1 | n/a | 0 |
Antoni | 1 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Bailey | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 1 |
Cao-Nguyen | 0 | 1 | 0 | 0 | 1 | 1 | n/a | 1 |
Ghirri | 1 | 1 | 1 | 1 | 0 | n/a | n/a | 0 |
Metzger | 1 | 1 | 1 | 0 | 0 | n/a | 1 | 0 |
Berninger | 2 | 0 | 0 | 0 | 0 | n/a | n/a | 1 |
Fornoff | 1 | 0 | 0 | 0 | 1 | 1 | n/a | 0 |
Martinez | 1 | 1 | 0 | 0 | 1 | 0 | n/a | 0 |
Mehl | 2 | 0 | 0 | 0 | 1 | 0 | n/a | 0 |
Rohlfs | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
Van Kerschaver | 1 | 0 | 0 | 0 | 1 | 1 | n/a | 0 |
Aidan | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
Total high quality |
11 high, 16 medium |
23 | 21 | 18 | 17 | 17 | 15 | 11 |
Total low quality | 5 | 9 | 11 | 14 | 15 | 8 | 2 | 21 |
Unclear | n/a | n/a | n/a | n/a | n/a | 7 | 15 | n/a |
n/a indicates unclear quality. PCHL: permanent childhood hearing loss; UNHS: universal newborn hearing screening.